What is the appropriate evaluation and management for a patient with a family history of rheumatoid arthritis who presents with new‑onset ankle pain without an obvious cause?

Evaluation and Management of New-Onset Ankle Pain with Family History of RA

This patient requires urgent rheumatology referral within 6 weeks and should undergo clinical examination with laboratory testing (RF, anti-CCP, ESR, CRP) and imaging to evaluate for early inflammatory arthritis. 1

Immediate Evaluation Approach

Clinical Assessment

Perform a focused examination specifically looking for:

• Joint swelling (not just pain) in the ankle or other joints
• Morning stiffness lasting >30 minutes
• Symmetric involvement of small joints (hands, feet, wrists)
• Tenderness on palpation of the ankle joint line
• Warmth or effusion suggesting active synovitis

The presence of any joint swelling associated with pain or stiffness mandates rheumatology referral within 6 weeks of symptom onset 1. Clinical examination is the primary method for detecting arthritis, though this can be confirmed with ultrasonography 1.

Laboratory Testing

Order the following tests immediately:

• Anti-CCP antibodies (most specific for RA, positive even in seronegative cases) 2
• Rheumatoid factor (RF)
• ESR and CRP (acute phase reactants)
• Consider ANA if clinical picture suggests other autoimmune conditions

Critical point: Anti-CCP positivity is highly predictive of RA even when RF is negative, and family history increases pre-test probability 2. These serologic markers, combined with acute phase reactants, are essential risk factors for persistent and erosive disease 1.

Imaging Strategy

Start with plain radiographs of the affected ankle and bilateral hands/feet to establish baseline and detect early erosions 3.

If clinical suspicion remains high despite negative initial workup:

• Ultrasonography is the preferred next step—it outperforms clinical examination in detecting synovitis, erosions, and provides prognostic information about disease progression 3
• US findings that increase probability of inflammatory arthritis to 50-94% include: erosions, synovial hypertrophy, and hyperemia on Doppler 3
• MRI with gadolinium is more sensitive than US for early RA, particularly for detecting bone marrow edema and synovitis, which predict progression 3

Management Algorithm

If Inflammatory Arthritis is Confirmed or Highly Suspected

Within 3 months of symptom onset, patients at risk of persistent arthritis should start DMARDs, even without meeting full classification criteria 1. Risk factors include:

• Positive RF or anti-CCP
• Elevated ESR/CRP
• Multiple swollen joints
• Imaging evidence of synovitis or erosions
• Family history of RA

First-line treatment: Methotrexate is the anchor drug and should be part of the initial strategy unless contraindicated 1.

Symptomatic Management During Workup

• NSAIDs: Use minimum effective dose for shortest duration after assessing GI, renal, and cardiovascular risks 1
• Glucocorticoids: Consider short-term use (<6 months) at lowest necessary dose to reduce pain and swelling 1
• Intra-articular glucocorticoid injection into the ankle can provide rapid local symptom relief while awaiting rheumatology evaluation 1

Critical Pitfalls to Avoid

1. Don't delay referral waiting for positive serology: Up to 30% of RA patients are seronegative for RF, but anti-CCP may still be positive 2. Clinical presentation with family history warrants urgent evaluation regardless.

2. Don't dismiss monoarticular presentation: While RA classically presents with symmetric polyarthritis, it can begin with single joint involvement that later becomes polyarticular 2. The ankle is involved in approximately 20% of initial RA presentations 4.

3. Don't attribute symptoms solely to mechanical causes: Even with coexisting osteoarthritis or obesity, new inflammatory symptoms require evaluation for RA 2.

4. Don't wait for radiographic changes: Plain films are often normal in early disease. Erosions on X-ray indicate established disease—US and MRI detect inflammation months to years earlier 3.

Timing is Critical

The 6-week window for rheumatology referral is evidence-based: patients under rheumatologist care receive earlier diagnosis, start treatment sooner, and have better long-term outcomes regarding joint damage and physical function 1. The goal is to initiate DMARDs within 3 months of symptom onset to prevent irreversible joint destruction 1.

Bottom line: Given the family history and new-onset ankle pain, this patient sits in a high-risk category. Aggressive early evaluation and treatment—if inflammatory arthritis is confirmed—will significantly impact long-term morbidity and quality of life.